JTEK LIMITED
Company number 14034199 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
JTEK LIMITED - Analysis Report
Company Number: 14034199
Analysis Date: 2025-07-20 16:47 UTC
Financial Health Assessment of JTEK LIMITED
1. Financial Health Score: B
Explanation:
JTEK LIMITED shows a significant turnaround from the previous financial years, moving from negative net current assets and shareholders' funds to a positive and improved financial position. The company’s net current assets have grown from a deficit of £2,982 in 2023 to a surplus of £25,704 in 2024. While this indicates a healthy recovery and strengthening of the company's financial "pulse," the company is still relatively young (incorporated in 2022) and small (Micro account category), which naturally limits scale and resilience. The absence of profit and loss details makes it harder to fully assess profitability and cash flows, but the working capital position is a strong positive sign.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Current Assets | 75,014 | Strong increase (+£68,055) indicating improved liquidity and cash or receivables on hand. |
| Current Liabilities | 49,310 | Increased liabilities but well covered by current assets, showing manageable short-term obligations. |
| Net Current Assets | 25,704 | Positive working capital, showing liquidity "breathing room" to meet short-term debts. |
| Shareholders Funds (Equity) | 25,704 | Positive equity indicates company value and capital buffer; improved from previous deficit. |
| Director’s Advances | 54,199 | Significant director loans suggest reliance on shareholder funding; must be monitored carefully. |
| Average Number of Employees | 1 | Micro business scale with minimal staffing, low fixed costs but limited capacity. |
- Liquidity: The company's "cash flow pulse" appears healthy with net current assets positive, indicating it can meet short-term obligations.
- Solvency: Positive shareholders’ funds show the company is solvent with assets exceeding liabilities.
- Funding: Director’s advances have increased substantially (from £2,141 to £54,199), indicating dependency on insider financing which is a symptom to watch for potential liquidity stress if external funding is unavailable.
3. Diagnosis
JTEK LIMITED has shown clear signs of recovery and financial stabilization over its first two years of operation. The company moved from a state of distress — negative working capital and shareholders’ funds — into a healthier financial condition by the year ending April 2024. This improvement suggests effective management intervention or increased business activity leading to better asset accumulation or receivables.
However, the reliance on director advances as a funding source is a notable symptom of underlying funding constraints. While such internal loans can provide vital support in the early stages, they can also mask liquidity issues if not repaid or replaced by sustainable revenue streams. The company operates with minimal staff, which keeps overheads low but may limit growth potential or operational flexibility.
The company’s financial statements are unaudited but prepared under micro-entity provisions, which is standard for its size and category. The absence of detailed profit and loss data and cash flow statements limits a full clinical picture, but the balance sheet "vital signs" are reassuring.
4. Recommendations
- Strengthen Revenue and Profitability: Focus on increasing sales and managing costs to reduce reliance on director loans. Healthy operating profits will improve cash flow and reduce funding risks.
- Monitor Director Advances: Establish a clear repayment plan or convert these into equity if possible to reduce debt burden and improve balance sheet quality.
- Cash Flow Management: Maintain a tight control on cash inflows and outflows to sustain positive net current assets and avoid liquidity “arrhythmias.”
- Plan for Growth: Consider incremental hiring or investments aligned with business expansion to avoid operational bottlenecks.
- Prepare for Audits or Reviews: As the company grows beyond micro thresholds, prepare for more robust financial reporting to attract external funding or partnerships.
- Regular Financial Health Checks: Continue periodic diagnostic reviews of key metrics to detect early symptoms of financial stress.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.